HDL Therapeutics

OverviewSuggest Edit

HDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis. It offers PDS-2 System, a therapeutic device that transforms a patient’s own plasma into an atherosclerosis reversal agent for the regression of plaque in coronary arteries of patients with Homozygous Familial Hypercholesterolemia (HoFH).
TypePrivate
Founded2009
HQVero Beach, FL, US
Websitehdltherapeutics.com

Locations

HDL Therapeutics is headquartered in
Vero Beach, United States

Location Map

Latest Updates

Employees (est.) (Mar 2020)7
Cybersecurity ratingAMore

Key People/Management at HDL Therapeutics

Michael M. Matin

Michael M. Matin

Chairman of the Board, CEO
D. J. Brignola

D. J. Brignola

Chief Financial Officer
H. Bryan Brewer

H. Bryan Brewer

Chief Scientific Officer
Nicholas G. Rothwell

Nicholas G. Rothwell

VP, Global Supply
Timothy J. Perlman

Timothy J. Perlman

VP, Systems Development & Clinical Operations
Lori A. Carr

Lori A. Carr

VP, Quality Management & Regulatory Affairs
Show more

HDL Therapeutics Office Locations

HDL Therapeutics has an office in Vero Beach
Vero Beach, FL, US (HQ)
601 21st St #300
Show all (1)

HDL Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2009

HDL Therapeutics total Funding

$7.4 m

HDL Therapeutics latest funding size

$3 m

Time since last funding

a year ago
HDL Therapeutics's latest funding round in October 2019 was reported to be $3 m. In total, HDL Therapeutics has raised $7.4 m
Show all financial metrics

HDL Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

HDL Therapeutics Online and Social Media Presence

Embed Graph

HDL Therapeutics Frequently Asked Questions

  • When was HDL Therapeutics founded?

    HDL Therapeutics was founded in 2009.

  • Who are HDL Therapeutics key executives?

    HDL Therapeutics's key executives are Michael M. Matin, D. J. Brignola and H. Bryan Brewer.

  • How many employees does HDL Therapeutics have?

    HDL Therapeutics has 7 employees.

  • Who are HDL Therapeutics competitors?

    Competitors of HDL Therapeutics include BioCardia, FIRE1 and ElectroCore.

  • Where is HDL Therapeutics headquarters?

    HDL Therapeutics headquarters is located at 601 21st St #300, Vero Beach.

  • Where are HDL Therapeutics offices?

    HDL Therapeutics has an office in Vero Beach.

  • How many offices does HDL Therapeutics have?

    HDL Therapeutics has 1 office.